StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report released on Thursday morning. The firm issued a hold rating on the stock.
Milestone Scientific Price Performance
Shares of NYSE MLSS opened at $0.99 on Thursday. The stock has a market capitalization of $77.60 million, a price-to-earnings ratio of -14.14 and a beta of 1.12. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.39. The firm’s 50 day simple moving average is $0.97 and its 200-day simple moving average is $0.96.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC boosted its holdings in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares in the last quarter. Carnegie Investment Counsel boosted its position in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the period. Finally, World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the 3rd quarter valued at about $91,000. Institutional investors and hedge funds own 5.79% of the company’s stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
- Five stocks we like better than Milestone Scientific
- How to trade using analyst ratings
- Markets Think Robinhood Earnings Could Send the Stock Up
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains?
- 3 REITs to Buy and Hold for the Long Term
- AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.